Distribution and prognostic value of left ventricular global longitudinal strain in elderly patients with symptomatic se
- PDF / 1,514,034 Bytes
- 11 Pages / 595.276 x 790.866 pts Page_size
- 37 Downloads / 174 Views
RESEARCH ARTICLE
Open Access
Distribution and prognostic value of left ventricular global longitudinal strain in elderly patients with symptomatic severe aortic stenosis undergoing transcatheter aortic valve replacement Jonas Agerlund Povlsen1* , Vibeke Guldbrand Rasmussen1, Henrik Vase1, Kaare Troels Jensen1, Christian Juhl Terkelsen1, Evald Høj Christiansen1, Mariann Tang2, Anders Lehmann Dahl Pedersen1 and Steen Hvitfeldt Poulsen1
Abstract Aims: The aim of present study was to examine the preoperative prevalence and distribution of impaired left ventricular global longitudinal strain (LVGLS) in elderly patients with symptomatic aortic stenosis (AS) undergoing transcutaneous aortic valve replacement (TAVR) and to determine the predictive value of LVGLS on survival. Methods: We included 411 patients with symptomatic severe AS treated with TAVR during a 5-year period, where a baseline echocardiography including LVGLS assessment was available. Results: Mean age was 80.1 ± 7.1 years and aortic valve area (AVA) index 0.4 ± 0.1 cm2. 78 patients died during a median follow-up of 762 days. Mean left ventricular ejection fraction (LVEF) was 50 ± 13% and mean LVGLS was − 14.0%. LVEF was preserved in 60% of patients, while impaired LVGLS > − 18% was seen in 75% of the patients. Previous myocardial infarction, LVEF − 14%, low gradient AS ( 30 mmHg were identified as significant univariate predictors of all-cause mortality. On multivariate analysis LVGLS > − 14% (HR 1.79 [1.02–3.14], p = 0.04) was identified as the only independent variable associated with allcause mortality. Reduced survival was observed with an impaired LVGLS > − 14% in the total population (p − 14% was an independent predictor of all-cause mortality, and survival was reduced if LVGLS > − 14%. Keywords: Global longitudinal strain, Aortic stenosis, TAVR, Echocardiography
*Correspondence: [email protected] 1 Department of Cardiology, Aarhus University Hospital, Palle Juul‑Jensens Boulevard 99, 8200 Aarhus N, Denmark Full list of author information is available at the end of the article
Background Surgical aortic valve replacement (SAVR) is considered gold standard therapy in severe aortic stenosis (AS) alleviating symptoms, improving quality of life and prolonging survival [1]. Transcatheter aortic valve
© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly
Data Loading...
